ALEC
NASDAQ · Biotechnology
Alector Inc
$2.63
+0.10 (+3.95%)
Open$2.55
Previous Close$2.53
Day High$2.84
Day Low$2.54
52W High$2.76
52W Low$1.09
Volume—
Avg Volume1.89M
Market Cap339.51M
P/E Ratio—
EPS$-1.09
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+709.9% upside
Current
$2.63
$2.63
Target
$21.30
$21.30
$14.71
$21.30 avg
$34.17
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 31.24M | 57.85M | 87.33M |
| Net Income | -212,223,311 | -353,640,029 | 8.20M |
| Profit Margin | -679.2% | -645.2% | 9.4% |
| EBITDA | -223,142,634 | -392,493,061 | 10.19M |
| Free Cash Flow | — | — | 6.96M |
| Rev Growth | -46.0% | -46.0% | +6.5% |
| Debt/Equity | 0.32 | 0.32 | 0.50 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |